<i>Ruminococcus gnavus</i> ameliorates atopic dermatitis by enhancing Treg cell and metabolites in BALB/c mice

Abstract

Immune modulation by orally administered R. gnavus may alleviate AD symptoms through the enhancement of regulatory T-cell counts and short-chain fatty acids production in AD mice.